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Congenital microcoria (MCOR) is a rare autosomal-dominant disorder characterized by inability of the iris to dilate owing to absence of
dilator pupillae muscle. So far, a dozen MCOR-affected families have been reported worldwide. By using whole-genome oligonucleotide
array CGH, we have identified deletions at 13q32.1 segregating with MCOR in six families originating from France, Japan, and Mexico.
Breakpoint sequence analyses showed nonrecurrent deletions in 5/6 families. The deletions varied from 35 kbp to 80 kbp in size, but
invariably encompassed or interrupted only two genes: TGDS encoding the TDP-glucose 4,6-dehydratase and GPR180 encoding the
G protein-coupled receptor 180, also known as intimal thickness-related receptor (ITR). Unlike TGDS which has no known function
in muscle cells, GPR180 is involved in the regulation of smooth muscle cell growth. The identification of a null GPR180mutation segre-
gating over two generations with iridocorneal angle dysgenesis, which can be regarded as a MCOR endophenotype, is consistent with
the view that deletions of this gene, with or without the loss of elements regulating the expression of neighboring genes, are the cause of
MCOR.Inherited congenital microcoria (MCOR) (MIM 156600),
also referred to as congenital miosis, is a rare inborn error
of iris development. It is characterized by a small pupil
(diameter < 2 mm) that dilates poorly or not at all in
response to topically administered mydriatic drugs. Dila-
tion inability results from absent or incompletely devel-
oped dilator pupillae muscle. The sphincter pupillae
muscle, which acts in opposition to the dilator muscle to
cause constriction of the pupil, is unaltered. In addition
to abnormal dilator pupillae muscle, the miotic iris is
thin and displays abnormal stroma and iridocorneal
angle.1–4 Iris thinning is consistent with transillumination
of miotic irises and high sensitivity to light. High myopia
and glaucoma are frequently associated with this condi-
tion.5–8
MCOR is a bilateral disease transmitted as an autosomal-
dominant trait with complete penetrance. A unique 8 Mb
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The Amlinkage analysis9 in a large multigenerational French pedi-
gree first described in 1964.10 Genemapping in some other
families confirmed linkage to this locus11 whereas some
others were inconsistent with the 13q31–q32 region, sup-
porting genetic heterogeneity of the disease.12
Here, we report a study combining Sanger sequencing
and array comparative genomic hybridization (aCGH),
which allowed the identification of the molecular defect
underlying the disease at the 13q31–32 locus.
We obtained DNA samples of affected and unaffected
members of six MCOR-affected families originating from
France, Japan, and Mexico (FR1 and FR2, JP1 and JP2,
MX1 and MX2, respectively). Three of these families
were previously reported (FR1, the original family that
allowed mapping of the MCOR locus on chromosome
13q31–q32;9,10 JP1,6 and MX14). The pedigrees of the
families are presented in Figure 1. The study was approved
by ethics committees of each participating institution,INE – Institute of Genetic Diseases, Paris Descartes University, 75015 Paris,
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Figure 1. Pedigrees of the Six Families Segregating MCOR
Autosomal-dominant transmission is supported by father-to-son transmission in all six families. Individual numbers in pedigrees FR19
and JP16 are those previously reported. Available DNA can be identified by the presentation of their genotype at the 13q32.1 locus (Del,
deletion; þ, wild-type allele). Individuals affected with MCOR who were examined by gonioscopy (asterisk) had all iridocorneal angle
dysgenesis.namely Paris Ile-de-France II; University of Occupational
and Environmental Health, Japan; and Instituto de Oftal-
mologia Conde de Valenciana, Mexico City. Individuals
participating to the study provided informed consents
for molecular analyses.
Sanger sequencing of the coding region and intron-exon
boundaries of genes lying within the 8 Mb MCOR interval
on 13q31–q32, and whole-exome sequencing combined
with linkage analysis failed to detect candidate disease-
causing variants segregating with the disease in families
FR1 and JP1, respectively (Table S1, Figure S1). Considering
the strong linkage at the locus in FR1 (Zmax ¼ 9.79,
Q ¼ 0),9 we assumed that the mutation in this family
was present in an unscreened region or that it might con-
sist in a genomic rearrangement undetectable by PCR-
based screening methods. To assess this latter hypothesis,
we subjected the DNA of an affected individual (FR1_III7,
Figure 1) to CGH on high-resolution oligonucleotide mi-
croarray (Affymetrix Cytogenetics Whole-Genome 2.7M
Array). Calculation of test over reference Log2 intensity ra-
tios identified a 54.8 kbp deletion in the 13q32.1 region
(Figures 2 and S2). We amplified the junction fragment632 The American Journal of Human Genetics 96, 631–639, April 2, 2by subjecting the genomic DNA of the index case to PCR
by using primers designed just outside of the predicted
deletion boundaries (Table S2, Figure S3). Direct sequenc-
ing of the 1.1 kb intervening segment showed that the
deletion extended from 95,227,374 to 95,277,864 (posi-
tions on chromosome 13 according to the Genome Refer-
ence Consortium Human Build 37) with centromeric
and telomeric breakpoints in intron 11 and intron 8 of
the tail-to-tail genes: TDP-glucose 4,6-dehydratase (TGDS
[RefSeq accession number NM_014305.2]) and the G pro-
tein-coupled receptor 180 (GPR180 [RefSeq NM_180989.5],
also known as intimal-thickness-related receptor, ITR
[MIM 607787]), respectively (Table 1 and Figure 2).
Interestingly, multiplex PCR of short fluorescent frag-
ments (QMPSF)13 using primer pairs specific to GPR180,
TGDS, and a control gene (CFTR [RefSeq NM_000492.3],
Table S3) suggested hemizygosity at 13q32.1 in the other
French family as well as the two Japanese and twoMexican
MCOR-affected families (Figure S4). In all five families,
array CGH confirmed the presence of 13q32.1 deletions,
which estimated sizes ranging from 39 kbp to 88.9 kbp
(Figure S2). Direct sequencing of intervening segments015
Figure 2. Overview of the 13q32.1 Deletions Identified in MCOR
Overview of the 13q32.1 locus (chr13: 95,110,000–95,375,000; hg19) with custom tracks showing the delineated deletions presented in
this study (horizontal red bars). At the top, the RefSeq Genes Track is included. In addition, ENCODE and conservation tracks are
displayed.amplified with primers designed just outside of the pre-
dicted breakpoints (Table S2) showed that the deletions
extended from 95,241,606 to 95,276,905 (35.3 kbp encom-
passing 4/12 TGDS and 7/9 GPR180 exons), 95,228,262
to 95,300,908 (72.6 kbp encompassing 11/12 TGDS
exons, GPR180, and mir_562), 95,236,251 to 95,309,380
(73.1 kbp encompassing 4/12 TGDS exons, GPR180,
mir_562, and 5S_rRNA), and 95,225,217 to 95,305,083
(79.9 kbp encompassing GPR180, mir_562, and 5S_rRNA)
in families FR2, JP1, JP2, and MX1, respectively (Table 1,
Figure 2).
In family MX2, we failed to amplify the intervening
segment using primers designed with array CGH data.
Considering that MX1 and MX2 families had the same
ethnic background and shared the same predicted distal
deletion breakpoint (Table 1 and Figure S2), we assumed
that both families could have inherited the same deletion
by descent and that, in corollary, lack of amplification of
the junction fragment in family MX2 could result from
incorrectly predicted proximal deletion breakpoint. By us-
ing the primers designed to amplify family MX1 junction
fragment, we were able to amplify family MX2 intervening
segment (Figure S3). Direct sequencing demonstrated that
the two families shared the exact same deletion (Table 1
and Figure 2). Analysis of microsatellite markers of chro-The Ammosome 13q31–q32 showed that the deletion was carried
by a common 6.4 Mb haplotype, suggesting that it might
have been transmitted within both families by a common
ancestor (Figure S5).
Deletion fragment-specific PCR assays based on the
amplification of intervening segments in all available
DNA samples (see Figure 1) allowed us to confirm the co-
segregation of the deletions with the disease in 4/6 families
(Figure S3). Segregation analysis could not be performed in
families FR2 and JP2 because of a lack of DNA samples. Pos-
itive PCR amplification of intragenic GPR180 fragments
confirmed heterozygosity of all deletions (not shown).
The copy-number variations identified in this study are
publicly available in the DECIPHER database as 301464,
301465, 301468, 301469, 301471, and 301472. None of
them have been previously reported in the DECIPHER
database, the Database of Genomic Variants (DGV), or in
the cohort of individuals affected with variable diseases
analyzed by array CGH at our institute (n ¼ 96; unpub-
lished data). However, chromosome 13q deletions are
not uncommon and cause a wide spectrum of phenotypes
correlated to the size and position of the deleted region. To
our knowledge, microcoria has not been described in indi-
viduals with 13q deletions encompassing the 13q32.1 re-
gion. However, microcoria could be overlooked or mighterican Journal of Human Genetics 96, 631–639, April 2, 2015 633
Table 1. Summary of 13q32.1 Deletions Identified by Array CGH and Characterized by Sequencing of the Intervening Segments
Family Individual
Deletions Predicted by Array CGH Actual Deletions
Centromeric Boundaries Telomeric Boundaries
Estimated
Size (kbp)
Deletion
Breakpoints Size (kbp)
Genes In ded
or Disru d
by the D tion
Sequence of the
Junction Fragmenta
þProbe
(position)
Probe
(position)
Probe
(position)
þProbe
(position)
FR1 III7 C-08UO9
(95,224,547)
C-08UOA
(95,225,723)
S-2NJCM
(95,276,735)
C-08UPK
(95,279, 378)
54.8 95,227,374–
95,277,864
50.5 TGDS,b G 180b AAAAATCAACTATTTTTTTCTTCTTAACTTCTAA
AGTCATTCAATACTGAACTTGGT/ATGCAAAT
ATGAATGTACATTCTTTTTTCTTTTACAGGAAT
ATTACACATTTGTG
FR2 II1 C-3ZRLF
(95,238,814)
C-3DRMS
(95,238,827)
C-6YHLK
(95,277,799)
C-4AEYA
(95,277,841)
39.0 95,241,606–
95,276,905
35.2 TGDS,b G 180b TCACCCAGGCTGGAGTGCAGTGGTGCAACC
TCAGCTCACTGCAAGCTCTGTCTCCC/GGG
TTCACGCCATTCTCCTGCCTCAGCCTCCC
GAGTAACTCGCGCCCACGCCCGGCTAAG
TTTTTGTATTTTTAGTAGAGACGGGGTTTCA
CCG
JP1 IV1 S-4RUHL
(95,211,097)
C-7G8VT
(95,211,706)
C-5TEUV
(95,299,777)
C-5TIVX
(95,300,029)
88.9 95,228,262–
95,300,908
72.6 TGDS,b G 180,
mir_562
ATCATTATTTTACATACATGTAAAAAAGAAAAA
AGCTACAATAATAATTATAAGACACCAGT/GTC
CTCTCTCAGCACAGCAGTTTACTTCTTCAGG
GGCAGCAGGAGAATCTCTCTGACTTC
JP2 III7 C-3ERLF
(95,238,800)
C-3DRMJ
(95,238,827)
S-4OHPW
(95,309,706)
C-6MYDV
(95,309,751)
70.9 95,236,251–
95,309,380
73.1 TGDS,b G 180,
mir_562, _rRNA
CGATGATCAATGTCACTTACAGTAAGAAAAAC
CCAAATTAAAAACTCAGAGATAC/TCTCATTCT
CCAGCTGAAATTCTCAGAAATAATGTCTATGC
CATGTACTTTCCCC
MX1 II3 S-3HRGB
(95,218,014)
C-6DQEK
(95,219,578)
C-6IBIF
(95,305,254)
C-4DJSK
(95,305,294)
87.2 95,225,217–
95,305,083
79.9 TGDS,b G 180,
mir_562, _rRNA
AACCAACTGAAAGGAGAAAAAAAGTTGATCTT
AGTTTATAGATGGATTGGCCTGTTC/TGAGCC
CCATAACAGTGAGCACCTCTAGCACCTAGGA
TGCCAGCTGCATGTAT
MX2 III1 C-7ALKO
(95,227,834)
C-3GDLS
(95,227,835)
C-6IBIF
(95,305,254)
C-4DJSK
(95,305,294)
77.5 95,225,217–
95,305,083
79.9 TGDS, G 80,
mir_562, _rRNA
AACCAACTGAAAGGAGAAAAAAAGTTGATCTT
AGTTTATAGATGGATTGGCCTGTTC/TGAGCC
CCATAACAGTGAGCACCTCTAGCACCTAGGA
TGCCAGCTGCATGTAT
aSequences shared between the proximal and distal sequences at the junction are underlined. The breakpoint (/) has been arbitrarily placed at the 50 of the i tical sequences. Nucleotide positions refer to the human genome
reference sequence (hg19 assembly) available at UCSC Genome Browser.
bPartial deletion of the gene (see Figure S2).
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not manifest owing to severe eye dysgenesis because about
one third of children with 13q deletion syndrome have iris
and choroid coloboma, glaucoma, cataracts, and cloudy
lenses. Together, these data are consistent with the causal-
ity of 13q32.1 deletions in MCOR.
Inspection of sequences surrounding MCOR deletion
breakpoints identified a duplicated sequence prone to
recurrent nonallelic homologous recombination (NAHR)
in a unique family (FR2, 37 bp sequence shared between
TGDS intron 4 and GPR180 intron 7 at positions
95,241,662–95,241,698 and 95,276,905–95,276,998,
respectively; Figure S6).
Recently, several microhomology-mediated repair mech-
anismshavebeendescribed in the etiologyofnon-recurrent
CNVs inhumandisease.14–16 Thesemechanisms,which are
guided by the surrounding genomic architecture, include
microhomology-mediated end-joining (MMEJ),17 fork
stalling and template switching (FoSTeS),18 microho-
mology-mediated break-induced replication (MMBIR),19
serial replication slippage (SRS),20 and break-induced SRS
(BISRS).21 Extensive bioinformatic analysis of MCOR dele-
tion breakpoints and surrounding genomic architecture
allowed the identification of perfectly matching 1 or 2
base pairs shared between the proximal and distal sequence
at the junctions, sequence motifs, and/or repetitive ele-
ments that are likely to stimulate the formation of the
13q32.1 deletions by increasing susceptibility of DNA
breakage or promote replication fork stalling (Table S4,
Figures S6 and S7). These findings are consistent with the
view that microhomology-mediated mechanisms underlie
non-recurrent MCOR deletions in families FR1, JP1, JP2,
MX1, and MX2.
The minimal common deletion disrupted GPR180 and
TGDS (Table 1 and Figure 2), raising the possibility that
haploinsufficiency of one or the two genes, or alternatively
the loss of regulatory elements, might give rise to the
phenotype.
GPR180 encodes a 201-amino-acid G protein-coupled re-
ceptor22 of the Rhodopsin-like receptors family that in-
cludes hormones, neurotransmitters, and light receptors,
all ofwhich transduce extracellular signalsupon interaction
with guanine nucleotide-binding proteins and activating li-
gands.23 Very little is known about the function of GPR180.
However, it has been reported to be produced predomi-
nantly in vascular smoothmuscle cells where its expression
is upregulated in response to experimental injury.24 The
significant suppression of DNA synthesis and inability to
produce neointima in response to vascular injury in the
Gpr180/ mouse suggest that upregulation of Gpr180
signaling contributes to vascular smooth muscle growth.22
In addition, gene expression profiling in normal human tis-
sues has shown that it is highly expressed in myoepithelia
(salivary gland, endomyometrium, prostate, lung, and
liver).25 In the eye, GPR180 is less abundant than in
myoepithelia. However, it is listed in the top 20 genes
having a significantly higher expression in the iris
compared to the other ocular structures.26 Hence, consid-The Amering that the dilator pupillae arises during embryonic life
by the differentiation of iris epithelial cells intomyoepithe-
lial cells,27,28 GPR180 was regarded as a strong candidate
MCOR gene.
The Gpr180/ mouse had resistance to experimental
thickening of the intima but normal appearance, growth
rate, reproduction, and histology of major organs.22 We
examined Gpr180/ and Gpr180þ/ mice for anterior
segment development and iris function. We found that
both heterozygote and homozygote Gpr180-null eyes
were undistinguishable from adult age-matched controls
(Figures S8–S10). In particular, we found no iris transillu-
mination and normal drug-mediated mydriasis both in
heterozygote and homozygote Gpr180-null mice. How-
ever, inspection of our in-house exome database (>4,200
exomes) for GPR180 nonsense or frameshift variants with
an acceptable amount of reads (R10) identified a unique
heterozygote GPR180 nonsense mutation (c.343C>T
[p.Gln115*]). This variant was found in our own series of
individuals with neonatal retinal dystrophy, namely Leber
congenital amaurosis (LCA [MIM 204000]). Interestingly,
the ophthalmologic file of the blind individual harboring
the p.Gln115* substitution (II2, family FR3; Figure 3)
mentioned an abnormal iridocorneal angle at examination
of the anterior segment of the eye. The individual, her par-
ents, and her siblings consented to ophthalmological
examination and genetic analysis. Iridocorneal angle
dysgenesis was evidenced in all family members but the
mother and a brother affected with LCA (family FR3;
Figure 3). Evidence of father-to-son transmission demon-
strated autosomal-dominant transmission of the iridocor-
neal defect that segregated with the p.Gln115* substitu-
tion, independently from the autosomal-recessive retinal
disease (Figure 3). Whole-genome SNP genotyping data
generated via Affymetrix GeneChip Human Mapping
10K 2.0 Arrays were available in this family. Retrospective
analysis for linkage with the autosomal-dominant anterior
segment dysgenesis pointed to 15 candidate chromosomal
regions, including a region on 13q32.1 containingGPR180
(Figure S11). Retrospective analysis of exome data found
no heterozygote loss-of-function variants in any of these
regions other than the GRP180 p.Gln115* substitution,
supporting the role of GPR180 in the development of the
iridocorneal angle. Nevertheless, none of the five individ-
uals with both iridocorneal angle dysgenesis and the
p.Gln115* substitution had abnormal pupillary response
or iris transillumination. Considering that iridocorneal
angle dysgenesis is a constant symptom in congenital
microcoria linked to 13q32.1 (31/31, 5/5, 1/1, 2/2, and
3/3 of examined MCOR-affected individuals in families
FR1,5,9 JP1,6 JP2, MX1, and MX2, respectively; Figures 1
and 3), goniodysgenesis in family FR3 can be regarded as
a MCOR endophenotype.
The reason why heterozygosity for the p.Gln115* substi-
tution was not sufficient to cause the full range of MCOR
symptoms could reside in the production of a truncated
protein retaining some of its function. Alternatively,erican Journal of Human Genetics 96, 631–639, April 2, 2015 635
Figure 3. Pedigree, GPR180 Genotypes, and Gonioscopic Aspects in Families FR3 and FR1
The iris spicules (arrows) consistent with an abnormal development of the iridocorneal angle are seen in individuals harboring the
GPR180 c.343C>T (p.Gln115*) mutation only as well as in individual FR1_V1 affected with microcoria. Abbreviations are as follows:
MCOR, microcoria; GD, goniodysgenesis; LCA, Leber congenital amaurosis.premature termination codon (PTC) self-correcting mech-
anisms could be involved, in particular translational
read-through that has recently been reported to be
more abundant than expected in higher species, including
human.29 Nonsense-associated altered splicing (NAS),
which consists of selective exclusion of an in-frame exon
with a premature termination codon, is another possible
correcting mechanism.30–33 Recently, a nonsense muta-
tion in CEP290 that causes blindness has been shown to
induce exon skipping and to lead to a relatively mild
retinal phenotype.34 Because the skipping of GPR180
exon 2 would not disrupt the open reading frame, NAS
could explain why the p.Gln115* substitution is not as
detrimental as gene ablation.
The p.Gln115* substitution was not reported in the
Exome Aggregator database (ExAC), Exome Variant Server
(EVS), 1000 Genomes, or dbSNP datasets. However, we
identified in the ExAC database 12 other rare variants
that might cause protein truncation (six nonsense and
six frameshift mutations, 0.00004 < minor allele fre-
quency < 0.000008; Table S5). Provided that these
variants are confirmed, studying their molecular conse-
quence at the mRNA and/or the protein levels and
knowing the ophthalmologic status of carrier individuals
will certainly help in understanding the role of GPR180
in MCOR and goniodysgenesis. Meanwhile, to address
this important question, we screened the GPR180 exome
for mutations in a series of individuals having an eye
disease with goniodysgenesis, including ten individuals
with Axenfeld-Rieger anomaly or Peters anomaly (MIM
604229) and no PAX6, PITX2, FOXC1, CYP1B1, MAF, or
MYOC mutation (n ¼ 5 and n ¼ 5, respectively), and
11 index cases of primary congenital glaucoma (n ¼ 9)
or juvenile glaucoma (n ¼ 2) with no CYP1B1 mutations.
Primer sequences are given in Table S6. No GPR180 can-
didate disease variants were identified in GPR180 exon
and intron-exon boundaries in any of the individuals.636 The American Journal of Human Genetics 96, 631–639, April 2, 2Despite strong arguments in favor of the involvement of
GPR180 in MCOR, in the absence of 13q32.1 deletions
that do not disrupt TGDS or of a GPR180 mutation that
causes the full MCOR phenotype, we cannot formally
exclude that haploinsufficiency of GPR180 is necessary,
but not sufficient, for MCOR to manifest.
The second gene lost or disrupted in MCOR-affected
individuals, TGDS, encodes the dTDP-D-glucose 4,6-
dehydratase, an evolutionarily conserved NAD-dependent
sugar epimerase/dehydratase of the short chain dehy-
drogenase/reductase extended-type family (SDR2E1,
EC:4.2.1.46). In human, SDR enzymes display a wide sub-
strate spectrum, ranging from steroids, alcohols, sugars,
and aromatic compounds to xenobiotics.35 TGDS catalyzes
the dehydration of dTDP-alpha-D-glucose into dTDP-4-de-
hydro-6-deoxy-alpha-D-glucose. It contributes to deoxy-
sugar metabolism,35,36 but its exact function is unknown.
In bacteria, TGDS is essential to the biogenesis of cell enve-
lope components and antibiotics,37 and in C. elegans, it is
required for normal growth rates, larval development and
survival, reproduction, and coordinated locomotion.38 In
human eyes, TGDS expression is lower than that of
GPR180, and unlike GPR180, it has no preferential expres-
sion in the iris.26 More importantly, very recently, biallelic
TGDS mutations have been reported to cause Catel-
Manzke syndrome (MIM 302380), which is characterized
by Pierre Robin sequence (MIM 261800; HP:0000201)
and a unique form of bilateral hyperphalangy causing cli-
nodactyly of the index finger (HP:0009467).39 Neither
the affected individuals nor their heterozygote parents
are reported to have eye disease.39 Therefore, it is unlikely
that TGDS dysfunction in human is responsible forMCOR.
Finally, it cannot be excluded that full range of MCOR
symptoms are due to both the loss of GPR180 function
and to that of elements that regulate theexpressionofneigh-
boring genes by position effect. Inspection of the ENCODE
repository for transcription factor-binding site identified015
byChIP-seqdetectednoeye-specificbinding sites in the35.3
kbp sequence of the shortest MCOR deletion (Figure S12).
Likewise, inspection of the database of conserved non-cod-
ing orthologous regions (CONDOR) identified no highly
conserved non-coding elements (HCNE) in the 35.3 kbp
MCOR minimal region. However, two genes involved in
eye development are located close to the MCOR region,
namely DCT (MIM 191275), which encodes the dopa-
chrome tautomerase, and SOX21 (MIM 604974), which
encodes SRY-related high-mobility-group box 21.
DCT is located 110 kbp upstream of proximal boundary
of the minimal interval (Figure 2). DCT functions down-
stream of tyrosinase (TYR [MIM 606933]) and tyrosi-
nase-related protein-1 (TRP1 [MIM 115501]) in the
biosynthetic pathway of eumelanin in pigment cells. In
the mouse, Dct mutations cause the Slaty phenotype in
which the iris is normal in the first months of life. Later
on, age-related dispersed pigment across the surface
of the iris combined with mild transillumination is
noted.40 To our knowledge, no DCT mutation is reported
in human disease so far but ten loss-of-function alleles are
described in EVS. One of these variants, p.Tyr75Serfs*50 is
homozygous in 12/6,249 individuals, making unlikely a
contribution of DCT loss of function in MCOR. However,
considering that pigmentation has a role on the develop-
ment of the neuroretina,41,42 it cannot be excluded that
13q32.1 deletions cause DTC overexpression and dysregu-
late iris development mechanisms.
SOX21 is located 75 kbp upstream of the distal boundary
of the minimal MCOR interval (Figure 2). SOX21 has been
reported to be a general mediator of the effects of SOX2,43
whose interaction with PAX6 is crucial to coordinate eye
development.44 It is known to be expressed in the devel-
oping lens in chickens45 and zebrafish.46 Additionally,
sox21b knock-down in the zebrafish causes lens malforma-
tion.47 In the mouse, complete inactivation of Sox21 has
been reported to cause cyclic alopecia,48 but the ocular
phenotype of the animal is unknown. Altered regulation
of SOX21 expression in MCOR-affected individuals cannot
be excluded.
In summary, here we report heterozygote 13q32.1 dele-
tions in 6/6 MCOR-affected families of variable ethnic
origin, which invariably encompass GPR180 and TGDS.
We suggest that GPR180 ablation, alone or in combination
with the loss of elements that regulate the expression of
neighboring genes by position effect, is the cause of the dis-
ease. Further studies will hopefully allow the identification
of the molecular mechanisms underlying this rare disease.
It should provide further insights into the development of
the anterior chamber of the eye, whose anomalies are an
important cause of visual loss due to glaucoma.Accession Numbers
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